No trial has tested starting all four HFrEF drugs at once. What the speed evidence actually supports, where guidelines split, and how to close the implementation gap.

Higher nurse-led supportive care intensity is associated with a better quality of life and lower symptom burden in patients ...

Bevacizumab is a cornerstone retina drug that has been used off-label for decades. Where the FDA-cleared branded version fits ...

They entered medicine amid COVID, prior authorizations, corporate ownership, and collapsing public trust. Some mourn what ...

Nearly 80% of young adults are found to have risk factors for cardiovascular-kidney-metabolic syndrome, which is tied to poor ...

Access to rheumatologists, medications, and nonpharmacologic care varies across Europe, with differences in specialist ...

Cases of AI psychosis accumulate as we learn what happens when a very convincing computerized companion never disagrees with ...

Optimal fludarabine exposure during lymphodepletion is associated with improved progression-free survival after CAR T-cell ...

Across the globe, recreational ketamine use has been increasing, along with a spike in young adult patients presenting with ...

For HR+ cases who initiated BP use only after diagnosis, breast cancer-specific mortality was significantly reduced (HR, 0.62 ...

Medicare Part D covers ustekinumab biosimilars, but patients pay nearly the same out-of-pocket costs regardless of the drug ...

Scientists identify a ‘microbial transmission’ signature — oral bacteria colonizing the gut — that flags gastrointestinal ...